Clarius Group, LLC - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 82 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Clarius Group, LLC ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$1,888,950
-18.4%
597,769
-0.0%
0.18%
+0.6%
Q2 2023$2,314,152
+39.7%
597,9720.0%0.18%
+27.0%
Q1 2023$1,656,382
+156606.0%
597,972
+1.8%
0.14%
+48.4%
Q4 2022$1,057
-99.9%
587,305
+16.4%
0.10%
-11.2%
Q3 2022$1,069,000
-21.2%
504,4040.0%0.11%
-20.7%
Q2 2022$1,357,000
-38.6%
504,404
+18.1%
0.14%
-22.9%
Q1 2022$2,211,0000.0%426,9240.0%0.18%0.0%
Q4 2021$2,211,000
+1874.1%
426,924
+2237.9%
0.18%
+1650.0%
Q3 2021$112,00018,2610.01%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders